Respiratory medication use in extremely premature (<29 weeks) infants during initial NICU hospitalization: Results from the prematurity and respiratory outcomes program

Background The use of medications to treat respiratory conditions of extreme prematurity is often based upon studies of adults or children over 2 years of age. Little is known about the spectrum of medications used or dosing ranges. To inform the design of future studies, we conducted a prospective...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric pulmonology 2020-02, Vol.55 (2), p.360-368
Hauptverfasser:	Greenberg, James M., Poindexter, Brenda B., Shaw, Pamela A., Bellamy, Scarlett L., Keller, Roberta L., Moore, Paul E., McPherson, Christopher, Ryan, Rita M.
Format:	Artikel
Sprache:	eng
Schlagworte:	bronchopulmonary dysplasia Bronchopulmonary Dysplasia - drug therapy Child Child, Preschool Drug therapy Female Gestational Age Humans Infant Infant, Low Birth Weight Infant, Newborn Infant, Premature Infant, Premature, Diseases - drug therapy Intensive care Intensive Care Units, Neonatal Male Neonatal care neonatal chronic lung disease Patient Discharge practice variation Premature birth Prospective Studies Respiratory therapy Respiratory Tract Diseases - drug therapy Steroids - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!